Your browser doesn't support javascript.
loading
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study.
Zeng, Jian; Mao, Wei-Min; Chen, Qi-Xun; Luo, Tao-Bo; Wu, Yi-Long; Zhou, Qing; Yang, Xue-Ning; Yan, Hong-Hong; Zhong, Wen-Zhao; Wang, Qun; Xu, Song-Tao; Wu, Lin; Shen, Yi; Liu, Yong-Yu; Chen, Chun; Cheng, Ying; Xu, Lin; Wang, Jun; Fei, Ke; Li, Xiao-Fei; Li, Jian; Huang, Cheng; Liu, Zhi-Dong; Xu, Shun; Chen, Ke-Neng; Xu, Shi-Dong; Liu, Lun-Xu; Yu, Ping; Wang, Bu-Hai; Ma, Hai-Tao.
Afiliación
  • Zeng J; Department of Thoracic Surgery, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, China.
  • Mao WM; Department of Thoracic Surgery, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, China. Electronic address: maowm@zjcc.org.cn.
  • Chen QX; Department of Thoracic Surgery, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, China.
  • Luo TB; Department of Thoracic Surgery, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, China.
  • Wu YL; Department of Pulmonary Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhou Q; Department of Pulmonary Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yang XN; Department of Pulmonary Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Yan HH; Department of Pulmonary Cancer, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhong WZ; Department of Pulmonary Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wang Q; Department of Thoracic Surgery, Fudan University Affiliated Zhongshan Hospital, Shanghai, China.
  • Xu ST; Department of Thoracic Surgery, Fudan University Affiliated Zhongshan Hospital, Shanghai, China.
  • Wu L; Department of Pulmonary Medicine, Hunan Cancer Hospital, Changsha, China.
  • Shen Y; Department of Thoracic Surgery, The Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
  • Liu YY; Department of Thoracic Surgery, Liaoning Cancer Hospital, Shenyang, China.
  • Chen C; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Cheng Y; Department of Oncology, Jilin Provincial Tumor Hospital, Changchun, China.
  • Xu L; Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing, China.
  • Wang J; Department of Thoracic Surgery, The People's Hospital of Peking University, Beijing, China.
  • Fei K; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Li XF; Department of Thoracic Surgery, Tangdu Hospital, Xi'an, China.
  • Li J; Department of Thoracic Surgery, Peking University First Hospital, Beijing, China.
  • Huang C; Department of Pulmonary Oncology, Fujian Cancer Hospital, Fuzhou, China.
  • Liu ZD; Department of Thoracic Surgery, Beijing Chest Hospital, Beijing, China.
  • Xu S; Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
  • Chen KN; Department of Thoracic Surgery, Beijing Cancer Hospital, Beijing, China.
  • Xu SD; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Liu LX; Department of Thoracic Surgery, West China Hospital of Sichuan University, Chengdu, China.
  • Yu P; Department of Thoracic Oncology, Sichuan Cancer Hospital, Chengdu, China.
  • Wang BH; Department of Oncology, The Northern Jiangsu People's Hospital, Yangzhou, China.
  • Ma HT; Department of Thoracic Surgery, The First Affiliated Hospital of Suzhou University, Suzhou, China.
Lung Cancer ; 150: 164-171, 2020 12.
Article en En | MEDLINE | ID: mdl-33186858

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: China